Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients

Xarelto Will Earn Decision Resources' Clinical Gold Standard Status for VTE Prophylaxis in 2012, According to a New Report from Decision Resources WALTHAM, Mass., March 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthc...

Researchers Find That Thromboembolism Can Be Safely Treated At Home

Researchers have stated to find in their study that blood clots can be effectively managed at the homes of the patients.// According to a study that was led by Clive Kearon, professor of medicine at McMaster University that has been published in the August 23 issue of JAMA, The Journal of the...

New Guidelines for Diagnosis of Venous Thromboembolism

AAFP and ACP have released new clinical practice guidelines for diagnosis and management of venous thromboembolism.// Venous thromboembolism is a condition that causes clotting in the veins. Key elements of the diagnosis guideline include the use of clinical prediction rules to establis...

ARIXTRA drug for venous thromboembolism

Venous thromboembolism is a complication causing increased bleeding which occurs after an orthopedic surgery procedure. // Professor Clifford W. Colwell has reported in the Journal of Arthroplasty that by giving a dose of ARIXTRA drug to these patients who underwent orthopedic surgery the complicat...

Travelers Face Greater Risk of Leg Clots

... Known as deep vein thrombosis (DVT) or venous thromboembolism (VTE), this serious condition can sometimes lead t...s, Dr. Samuel Z. Goldhaber, director of the Venous thromboembolism Research Group in the cardiovascular division of B...rvard Medical School, Boston, and director, Venous thromboembolism Research Group, cardiovascular division, Brigham a...

New Anticoagulant Pill Works Well in Trial

.... Rivaroxaban is a pill that blocks factor Xa, which is involved in blood clotting. In earlier studies, the drug was effective in preventing venous thromboembolism (blood clots in the legs) after orthopedic surgery, although some increased risk in bleeding episodes was seen. In this phase II trial, researchers te...

Quality measures improve outcomes more than hospital volume alone

...urgical site infection on the operative day, whether the antimicrobial was appropriate, whether serial compression devices were used to prevent venous thromboembolism on the operative day, and whether aspirin, beta-blockers, or statin lipid-lowering drugs were administered in the first two days after surgery. T...

NCCN Updates Supportive Care Guidelines for VTE

...community and academic settings. The NCCN Guidelines for Venous Thromboembolic Disease are one of the NCCN Guidelines for Supportive Care. Venous thromboembolism (VTE), commonly known as "economy class syndrome," includes both deep venous Thrombosis (DVT) and pulmonary embolism (PE), and is a common and life-th...

New Approach to Progesterone Supplementation in ART Revealed in Recently Published White Paper

...ingredients in ENDOMETRIN(R); a known missed abortion or ectopic pregnancy; liver disease; known or suspected breast cancer; active arterial or venous thromboembolism or severe thrombophlebitis, or a history of these events. About Ferring Pharmaceuticals Ferring Pharmaceuticals, part of the Ferring Group, ...

Journal Chest: April news briefs

...rts of 7,264 patients who underwent podiatric surgical procedures. Of the 16,804 total procedures recorded, overall incidence of post-procedure venous thromboembolism (VTE) was 0.30 percent. The incidence of VTE increased slightly with the presence of risk factors, including prior VTE, use of hormone replacement the...

Thromboembolism in Medical Technology

Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)

-Patients treated with Lovenox(R) (enoxaparin sodium injection) were also less likely to be readmitted to hospital within 90 days- BRIDGEWATER, N.J., Dec 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the results of a study that demonstrated total hospital direct medical cos...

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

Data to be Presented at the XXI Congress of the International Society on Thrombosis and Haemostasis SOUTH SAN FRANCISCO, Calif., April 04, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. today announced that it has received positive results from EXPERT, a Phase II study of its oral Factor Xa in...

The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke

Risk of Having a Venous ThromboEmbolism (VTE) is Reduced by a Significant 43% in Acute Ischemic Stroke Patients Treated With Clexane(R) / Lovenox(R) BRIDGEWATER, N.J., April 20, 2007 /PRNewswire-FirstCall/ -- Sanofi-aventis announced the publication of the PREVAIL (Prevention of VTE after Acute Is...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

GENEVA--(BUSINESS WIRE)--Jul 8, 2007 - Late-breaking Phase III clinical trial data presented today at the XXI International Society on Thrombosis and Haemostasis (ISTH) Congress demonstrate that once-daily rivaroxaban achieved superior efficacy in the prevention of venous thromboembolism (VTE) in p...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

EXCLAIM is the First International Study to Show That Extended Thromboprophylaxis Reduces VTE Risk in Acutely-ill Medical Patients With a Statistically Significant 44% PARIS, July 8, 2007 /PRNewswire-FirstCall/ --Sanofi-aventis announced today the results of the EXCLAIM (EXtended CLinical prophy...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Rivaroxaban, a New Oral, Once-Daily Direct Factor Xa Inhibitor, Shows a Significant Reduction in Deep Vein Thrombosis and Pulmonary Embolism Compared with Enoxaparin with Similarly Low Bleeding Rates GENEVA, July 8, 2007 - Late-breaking Phase III clinical trial data presented today at the XXI In...

Value of Genetic Testing for Preventing Blood Clots Unproven, According to New AHRQ Study

...ty and utility of genetic tests for FVL and prothrombin G20210A. This report, titled Outcomes of Genetic Testing in Adults with a History of Venous thromboembolism , is the fifth evidence report requested for EGAPP. The authors, who were led by Jodi Segal, M.D., of the AHRQ-supported Johns Hopkins Evidence-...

New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery

...n therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to ora...gesting that oral, not transdermal estrogen may increase the risk of venous thromboembolism in postmenopausal women." Transdermal estrogen therapies available by ...

CRESTOR(R) Reduced Risk of Blood Clots in the Veins

.../PRNewswire-FirstCall/ -- A new analysis from the JUPITER study shows that CRESTOR(R) (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p =0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

...tively as venous thromboembolism. "Venous thromboembolism is a serious public health problem that affects al...ilar to that of the placebo group. Venous thromboembolism occurred 11 times in both the nadroparin and place...mpared with idraparinux. Rates of recurrent venous thromboembolism (2.3 percent versus 3.2 percent) and fatal or non-...

Thromboembolism in Medical Products

Venous Thromboembolism (VTE), Qualitative

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Thromboembolism in Medical Dictionary

Thromboembolism

Clinical guideline 46: Venous thromboembolism (surgical). London, April 2007. ... Prevention of venous thromboembolism : the Seventh ACCP Conference on ... Thromboembolism information including symptoms, diagnosis, misdiagnosis, treatment, causes, patient stories, videos, forums, pre...

Estrogen

... Transdermal delivery of estrogen does not appear to be associated with the same ... Past users of oral estrogen had a similar risk of venous thromboembolism to ... Estrogen is a group of hormones that play an important role in the normal sexual ... The woman's ovaries produce most estrogen hormone...

Thromboembolism in Biological News

New research shows no link between aromatase inhibitors and cardiovascular problems

...ucing the risk of breast cancer recurring. Also, we should not forget the life-threatening toxicities associated with tamoxifen therapy such as venous thromboembolism (VTE) and endometrial cancer, which do not appear to be a problem with AIs. While AIs have not demonstrated the lipid-lowering properties of tamoxifen...

Thromboembolism in Biological Technology

Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter

...rm retrieval post device implantation if desired or deemed necessary by the treating physician, and can be used in the following conditions: pulmonary thromboembolism when anticoagulant therapy is contraindicated, failure of anticoagulant therapy in thromboembolic diseases, emergency treatment following massive PE, ...

The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment

...tcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism. 2002; 88:407-14. (4) Gerotziafas GT, Samama MM. Prophylaxis of venous thromboembolism medical patients. CurrOpin PulmMed. 2004; 10:356-365. (5) Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The Seventh A...

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

...ces after the date hereof, except when a duty arises under law. (1) Hillmen P, Muus P et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients. Blood. 2007;110:4123-4128) (2) Machado RF, Anthi A, Martin et al. N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Dea...

Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation

...t betrixaban is well tolerated over a range of dose levels. Portola may develop betrixaban for additional indications including prevention of venous thromboembolism (VTE) in medically ill patients and in those undergoing major orthopedic surgery, treatment and secondary prevention of VTE, and acute coronary syndro...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay

...that the US Food and Drug Administration (FDA) has granted 510(k) clearance to expand the intended use for the HemosIL D-Dimer assay to exclude venous thromboembolism (VTE) in outpatients suspected of deep venous thrombosis (DVT) and pulmonary embolism (PE), when used in conjunction with a clinical pretest probabili...

Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents

... JAMA, February 27, 2008 - Vol. 299. No. 8: 'Venous thromboembolism and Mortality Associated with Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia' BRIDGEWA...

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

... for the Evaluation of Patients at Risk for Venous thromboembolism in the Acute Hospital Care Setting) published toda...s particularly in medical patient." About venous thromboembolism (VTE) Venous thromboembolism is a general term used to describe the formation o...

Clexane(R)/Lovenox(R) Approved in Japan

...h, Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients undergoing orthopaedic surgery o...nee replacement and hip fracture surgery. Venous thromboembolism is a frequent and preventable complication among p... to greatly contribute to the prevention of venous thromboembolism and fulfil an important medical need for patients ...

49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases

...hts of the meeting include special symposia, education programs, special interest seminars, and scientific sessions. A special symposium on venous thromboembolism will provide an overview of this common clotting disorder from the patient, public health, and scientific sectors. Guest speaker Melanie Bloom, nation...

Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay

... - Now for Exclusion of Venous thromboembolism - LEXINGTON, Mass., Oct. 9 /PRNewswire/ -- Instrumentation Laboratory (IL...earance to expand the intended use for HemosIL D-Dimer HS to exclude venous thromboembolism (VTE) in outpatients suspected of deep vein thrombosis (DVT) and pulmonary ...

Thromboembolism in Biological Dictionary

Pulmonary veins

... the pulmonary veins can lead to violation of the pleural ... Information and resources pertaining to the pulmonary veins of the heart. ... thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) - Thromboembo... Pulmonary veins stenosis information including symptoms, diagnosis, misdiagn...